A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma

Chimeric antigen receptor (CAR) T-cell therapy is a new standard of care for patients with diffuse large B-cell lymphoma (DLBCL); however, studies including healthcare resource utilization (HRU) during routine care are lacking. Accordingly, a population-based study was conducted using linked adminis...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Lee Mozessohn, Pierre J. A. Villeneuve, Nibene H. Somé, Rebecca E. Mercer, Lisa Masucci, Tom Kouroukis, Christopher Bredeson, Suriya Aktar, Qi Guan, Anca Prica, Christine I. Chen, Danielle Rodin, Matthew C. Cheung, Munaza Chaudhry, Scott Gavura, Cassandra McKay, William W. L. Wong, Kelvin K. W. Chan
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2026-06-01
Schriftenreihe:	Current Oncology
Schlagworte:	chimeric antigen receptor T-cell therapy diffuse large B-cell lymphoma real-world evidence
Online-Zugang:	https://www.mdpi.com/1718-7729/33/6/366
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!